1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow Stereotactic ablative radiotherapy (SAR): new trials by email Literature Review of Stereotactic ablative radiotherapy (SAR) trials Research Report on Stereotactic ablative radiotherapy (SAR)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients Avelumab, Stereotactic ablative radiotherapy (SAR) - Metastatic Non-small Cell Lung Cancer (NSCLC) | Early Phase 1 | Completed | Megan Daly, MD | 8 | 2017-05-17 | 2021-10-20 |
Carcinoma, Non-Small-Cell Lung (1)
Megan Daly, MD (1)
United States (1)
Megan Daly, MD (1)